Recently, the innovative product Disposable Cardiac Pulsed Electric Field Ablation Catheter of Hangzhou Deno Electrophysiology Medical Technology Inc. was approved by China NMPA.

The product consists of a catheter and connecting cables, and is used in conjunction with Cardiac Pulsed Electric Field Ablation System of the Company to treat atrial fibrillation by controlling and releasing pulsed electric field energy with appropriate intensity, which selectively produces irreversible electroporation damage only to cardiac myocytes at the site of the lesion to be treated. This product provides additional options for the treatment of drug-refractory, recurring, symptomatic, and paroxysmal atrial fibrillation.

The NMPA will strengthen the post-marketing surveillance of the product to protect the safety of medical devices used by patients.